Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06026696

Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière

Cohorte de Maladies Neurovasculaires Prises en Charge à la Phase aiguë et Suivies à Lariboisière

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Neurovascular diseases can cause ischaemic or haemorrhagic strokes. While the most common, such as atherosclerosis are widely studied, others are less well known, such as arterial dissections or cerebral angiopathies. What's more, most studies are limited to a few years' follow-up and the longer-term evolution of patients is less well assessed. Patient follow-up data available in routine practice and specific enrollment through the headache emergencies of the Lariboisière neurovascular intensive care unit (USINV) could provide a particularly rich resource.

Conditions

Interventions

TypeNameDescription
OTHERfollow-upLong term follow-up

Timeline

Start date
2023-09-01
Primary completion
2033-09-01
Completion
2038-09-01
First posted
2023-09-07
Last updated
2023-09-07

Source: ClinicalTrials.gov record NCT06026696. Inclusion in this directory is not an endorsement.

Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière (NCT06026696) · Clinical Trials Directory